Taken together, these results strongly suggest that K‐234 and its derivatives identified as DAX1 inhibitors inhibit DHODH enzymatic activity to reduce the growth of Ewing's sarcomas. This evidence concerns the gene NR0B1 and Ewing sarcoma.